Connect with us

Blindspot by GroundNews

FDA Approves Novavax COVID-19 Shot but with Unusual Restrictions

Published

on

The FDA granted the company full approval for its vaccine for use only in adults 65 and older and those 12 to 64 who are at an increased risk from COVID-19.
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *